Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIOX Bioceres Crop Solutions	$4.30 -1.1%	$4.39	$3.51 ▼ $13.18	$269.66M	0.6	167,845 shs	85,141 shs
FSNB Fusion Acquisition Corp. II	$10.49	$10.49	$9.52 ▼ $10.75	$655.63M	0.01	N/A	N/A
RILY B. Riley Financial	$3.09 -4.3%	$3.94	$2.67 ▼ $40.09	$94.24M	1.34	1.96 million shs	439,142 shs
TRHC Tabula Rasa HealthCare	$10.50	$10.45	$3.15 ▼ $10.50	$284.13M	1.57	225,500 shs	N/A

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIOX Bioceres Crop Solutions	-1.15%	+3.86%	-1.83%	-40.11%	-63.93%
FSNB Fusion Acquisition Corp. II	0.00%	0.00%	0.00%	0.00%	0.00%
RILY B. Riley Financial	-4.33%	-2.22%	-26.78%	-33.83%	-89.61%
TRHC Tabula Rasa HealthCare	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIOX Bioceres Crop Solutions	2.6323 of 5 stars	3.7	4.0	0.0	0.0	2.0	0.0	1.3
FSNB Fusion Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RILY B. Riley Financial	0.5684 of 5 stars	0.0	2.0	0.0	0.0	1.4	2.5	0.6
TRHC Tabula Rasa HealthCare	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIOX Bioceres Crop Solutions	3.33	Buy	$8.63	100.58% Upside
FSNB Fusion Acquisition Corp. II	0.00	N/A	N/A	N/A
RILY B. Riley Financial	0.00	N/A	N/A	N/A
TRHC Tabula Rasa HealthCare	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest RILY, TRHC, FSNB, and BIOX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/22/2025	BIOX Bioceres Crop Solutions	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$8.00 ➝ $7.00
2/13/2025	BIOX Bioceres Crop Solutions	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$7.00 ➝ $6.50
2/7/2025	BIOX Bioceres Crop Solutions	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$13.00 ➝ $8.00
2/7/2025	BIOX Bioceres Crop Solutions	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$9.50 ➝ $7.00
1/28/2025	BIOX Bioceres Crop Solutions	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$13.00 ➝ $12.00

(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIOX Bioceres Crop Solutions	$407.73M	0.66	$0.37 per share	11.67	$5.56 per share	0.77
FSNB Fusion Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A	N/A
RILY B. Riley Financial	$1.44B	0.07	$0.61 per share	5.03	$11.76 per share	0.26
TRHC Tabula Rasa HealthCare	$299.52M	0.95	N/A	N/A	($2.10) per share	-5.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIOX Bioceres Crop Solutions	$3.24M	$0.02	215.11	11.32	N/A	0.58%	0.68%	0.28%	6/4/2025 (Estimated)
FSNB Fusion Acquisition Corp. II	$16.57M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
RILY B. Riley Financial	-$99.91M	-$27.77	N/A	∞	N/A	-48.04%	-236.88%	-11.40%	N/A
TRHC Tabula Rasa HealthCare	-$147.51M	-$3.85	N/A	N/A	N/A	-28.23%	N/A	-8.80%	N/A

Latest RILY, TRHC, FSNB, and BIOX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/21/2025	Q3 2024	RILY B. Riley Financial	N/A	-$4.97	N/A	-$9.39	N/A	$199.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIOX Bioceres Crop Solutions	N/A	N/A	N/A	N/A	N/A
FSNB Fusion Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
RILY B. Riley Financial	$2.00	64.72%	-7.17%	N/A	N/A
TRHC Tabula Rasa HealthCare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIOX Bioceres Crop Solutions	0.43	1.33	0.96
FSNB Fusion Acquisition Corp. II	N/A	N/A	N/A
RILY B. Riley Financial	N/A	3.43	3.43
TRHC Tabula Rasa HealthCare	N/A	1.57	1.47

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIOX Bioceres Crop Solutions	17.68%
FSNB Fusion Acquisition Corp. II	N/A
RILY B. Riley Financial	50.20%
TRHC Tabula Rasa HealthCare	61.88%

Insider Ownership

Company	Insider Ownership
BIOX Bioceres Crop Solutions	2.31%
FSNB Fusion Acquisition Corp. II	73.64%
RILY B. Riley Financial	32.90%
TRHC Tabula Rasa HealthCare	30.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIOX Bioceres Crop Solutions	500	62.71 million	N/A	Optionable
FSNB Fusion Acquisition Corp. II	2	62.50 million	3.87 million	Not Optionable
RILY B. Riley Financial	1,410	30.50 million	20.47 million	Optionable
TRHC Tabula Rasa HealthCare	1,027	27.06 million	18.86 million	Optionable

RILY, TRHC, FSNB, and BIOX Headlines

Recent News About These Companies

Tabula Rasa here to help rebuild cancer patients' confidence

April 19, 2025 | turnto23.com

Tabula Rasa rebrands as AnewHealth, names Brian Adams its new CEO

January 24, 2025 | bizjournals.com

Tabula Rasa rebrands as AnewHealth, names Brian Adams its new CEO

January 24, 2025 | bizjournals.com

Quince takes the next step with their new Tabula Rasa project

August 20, 2024 | bk.asia-city.com

Arvo Pärt’s ‘Tabula Rasa’ Returns to Vinyl

July 25, 2024 | udiscovermusic.com

ExactCare and Tabula Rasa HealthCare Rebrand Combined Organization as AnewHealth

July 10, 2024 | globenewswire.com

New dance series 'Tabula Rasa' set to showcase cutting-edge choreography

April 22, 2024 | thestar.com.my

Jalgaon: 'Tabula Rasa' Initiative To Encourage Young Voters

April 20, 2024 | freepressjournal.in

Daniel C Lubin's Net Worth

March 2, 2024 | benzinga.com

Leeds city centre bars Below Stairs and Tabula Rasa 'thrilled' to be named in UK's Top 50 Cocktail Bars

February 8, 2024 | msn.com

Tabula Rasa to go private after $570M acquisition

November 2, 2023 | njbiz.com

Tabula Rasa HealthCare gets stockholder nod for going-private transaction

October 31, 2023 | msn.com

Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners

October 31, 2023 | finance.yahoo.com

'Tabula Rasa Alfresco Bar': Hyderabad's new go-to place where art meets flavor

October 21, 2023 | newsmeter.in

Tabula Rasa HealthCare: Other Events

October 20, 2023 | cbonds.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, VRTV, HEP

October 8, 2023 | bakersfield.com

With 46% ownership, Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has piqued the interest of institutional investors

September 20, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Inc. News

September 6, 2023 | thestreet.com

Tabula Rasa HealthCare (TRHC) Price Target Increased by 23.38% to 10.54

August 31, 2023 | msn.com

Analysts review Tabula Rasa HealthCare Inc.’s rating

August 30, 2023 | knoxdaily.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RILY, TRHC, FSNB, and BIOX Company Descriptions

Bioceres Crop Solutions NASDAQ:BIOX

$4.30 -0.05 (-1.15%)

Closing price 04/25/2025 04:00 PM Eastern

Extended Trading

$4.30 0.00 (0.00%)

As of 04/25/2025 04:05 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Fusion Acquisition Corp. II NYSE:FSNB

$10.49 0.00 (0.00%)

As of 04/25/2025

Fusion Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire businesses in the wealth, financial advice, investment, and asset management sectors, as well as FinTech sector. Fusion Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.

B. Riley Financial NASDAQ:RILY

$3.09 -0.14 (-4.33%)

Closing price 04/25/2025 04:00 PM Eastern

Extended Trading

$3.16 +0.07 (+2.27%)

As of 04/25/2025 07:58 PM Eastern

B. Riley Financial, Inc., through its subsidiaries, provides financial services to corporate, institutional, and high net worth clients in North America, Australia, the Asia Pacific, and Europe. The company operates through six segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segments offers investment banking, equity research, institutional sales and trading, securities lending, fund and asset management, direct lending, venture capital, proprietary trading, and investment services; merger and acquisition, restructuring advisory, and recapitalization services; public and private equity offerings; and debt financing solutions. This segment also trades in equity securities. The Wealth Management segment provides wealth management and tax services. The Financial Consulting segment offers bankruptcy restructuring and turnaround management, forensic accounting and litigation support, valuation and appraisal, and real estate services. The Auction and Liquidation Segment provides auction and liquidation services. The Communications segment offers dial-up, mobile broadband and digital subscriber line services under the NetZero and Juno brands; cloud communication services; VoIP cloud-based technology and communication devices and subscription services through magicJack; and mobile phone voice, text, and data services and devices through Marconi Wireless. The Consumer segment sells laptop and computer accessories. The company was formerly known as Great American Group, Inc. and changed its name to B. Riley Financial, Inc. in November 2014. B. Riley Financial, Inc. was founded in 1973 and is headquartered in Los Angeles, California.

Tabula Rasa HealthCare NASDAQ:TRHC

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time